These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8327301)

  • 1. Chronic granulomatous disease of childhood: a saga of discovery and understanding.
    Quie PG
    Pediatr Infect Dis J; 1993 May; 12(5):395-8. PubMed ID: 8327301
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Annu Rev Med; 1992; 43():117-24. PubMed ID: 1316094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-gamma in the treatment of the chronic granulomatous diseases of childhood.
    Gallin JI
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 2):S100-5. PubMed ID: 1934607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood.
    Sechler JM; Malech HL; White CJ; Gallin JI
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4874-8. PubMed ID: 2838849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease.
    International Chronic Granulomatous Disease Cooperative Study Group
    N Engl J Med; 1991 Feb; 324(8):509-16. PubMed ID: 1846940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae.
    Rex JH; Bennett JE; Gallin JI; Malech HL; DeCarlo ES; Melnick DA
    J Infect Dis; 1991 Apr; 163(4):849-52. PubMed ID: 1901332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful interferon gamma therapy in a patient with X-linked chronic granulomatous disease, McLeod syndrome and hyper-IgE. Case report.
    Kantar A; Oggiano N; Gabbianelli R; Fabrizzi G; Giorgi PL
    Minerva Pediatr; 1994 Apr; 46(4):157-60. PubMed ID: 8084323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular effects of recombinant interferon gamma in chronic granulomatous disease.
    Newburger PE; Ezekowitz RA
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):267-76. PubMed ID: 2839459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins.
    Mühlebach TJ; Gabay J; Nathan CF; Erny C; Dopfer G; Schroten H; Wahn V; Seger RA
    Clin Exp Immunol; 1992 May; 88(2):203-6. PubMed ID: 1572085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phagocytes: Their protective activity and their genetic and acquired defects.
    Daughaday CC; Douglas SD
    Pediatr Ann; 1976 Jun; 5(6):359-68. PubMed ID: 179049
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon gamma.
    Ezekowitz RA; Dinauer MC; Jaffe HS; Orkin SH; Newburger PE
    N Engl J Med; 1988 Jul; 319(3):146-51. PubMed ID: 2838754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of IFN-gamma for liver abscesses in chronic granulomatous disease.
    Conte D; Fraquelli M; Capsoni F; Giacca M; Zentilin L; Bardella MT
    J Interferon Cytokine Res; 1999 Jul; 19(7):705-10. PubMed ID: 10454340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma in the management of chronic granulomatous disease.
    Gallin JI
    Rev Infect Dis; 1991; 13(5):973-8. PubMed ID: 1962114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of long-term interferon gamma therapy in patients with chronic granulomatous disease.
    Bemiller LS; Roberts DH; Starko KM; Curnutte JT
    Blood Cells Mol Dis; 1995; 21(3):239-47. PubMed ID: 8673477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment.
    Naderi beni F; Fattahi F; Mirshafiey A; Ansari M; Mohsenzadegan M; Movahedi M; Pourpak Z; Moin M
    Int Immunopharmacol; 2012 Apr; 12(4):689-93. PubMed ID: 22330085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease.
    Bernhisel-Broadbent J; Camargo EE; Jaffe HS; Lederman HM
    J Infect Dis; 1991 Apr; 163(4):908-11. PubMed ID: 1901336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of therapy with recombinant human interferon-gamma on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease.
    Condino-neto A; Muscará MN; Bellinati-Pires R; Carneiro-Sampaio MM; Brandão AC; Grumach AS; De Nucci G
    J Interferon Cytokine Res; 1996 May; 16(5):357-64. PubMed ID: 8727075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma is effective in reducing infections in the mouse model of chronic granulomatous disease (CGD).
    Jackson SH; Miller GF; Segal BH; Mardiney M; Domachowske JB; Gallin JI; Holland SM
    J Interferon Cytokine Res; 2001 Aug; 21(8):567-73. PubMed ID: 11559434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis.
    Lau YL; Chan GC; Ha SY; Hui YF; Yuen KY
    Clin Infect Dis; 1998 Jan; 26(1):226-7. PubMed ID: 9455564
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of interferon-gamma treatment to chronic granulomatous disease patients with splice site mutations.
    Nunoi H; Ishibashi F; Mizukami T; Hidaka F
    Jpn J Infect Dis; 2004 Oct; 57(5):S25-6. PubMed ID: 15507763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.